MCAS

IBS vs MCAS: When Your Gut Symptoms Are an Immune System Problem

Mast cell activation syndrome causes GI symptoms including abdominal pain, diarrhea, nausea, and bloating that overlap substantially with IBS. The distinguishing features are multi-system involvement (flushing, hives, brain fog, rapid heart rate), symptom triggers from histamine-rich foods, and elevated tryptase or urinary histamine metabolites. MCAS patients are 3 times more likely to also have SIBO.

Last updated 2026-04-25

Current Consensus

  • MCAS produces GI symptoms including abdominal pain, diarrhea, nausea, and bloating that are clinically indistinguishable from IBS in isolation.
  • Multi-system symptoms (dermatologic, cardiovascular, neurologic) alongside GI complaints should raise suspicion for MCAS over isolated IBS.
  • Serum tryptase, 24-hour urinary N-methylhistamine, and urinary prostaglandin D2 metabolites are the primary diagnostic markers.
  • MCAS patients have approximately 3 times higher prevalence of SIBO compared to the general population.
  • H1 and H2 antihistamines and mast cell stabilizers are the primary treatment approach, distinct from standard IBS therapies.

Open Questions

  • Whether MCAS is underdiagnosed or overdiagnosed in the functional GI community.
  • The mechanism linking mast cell activation to SIBO and whether treating one improves the other.
  • Standardized diagnostic criteria for MCAS that are universally accepted across allergy and gastroenterology specialties.
  • Whether a low-histamine diet produces clinically meaningful improvement in MCAS patients with GI-predominant symptoms.
  • The overlap between MCAS, Ehlers-Danlos syndrome, and POTS (the so-called 'triad') and its implications for GI symptoms.

Not sure if this applies to you?

Our misdiagnosis quiz evaluates your symptoms against 14 conditions commonly confused with IBS.

Take the Quiz

Medical Disclaimer: The content in this section is for informational and educational purposes only. It does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare professional before making changes to your health regimen. GLP1Gut is a tracking tool, not a medical device.